fda ruling on semaglutide approves Ozempic® (semaglutide) as the only GLP-1 RA to reduce the risk of worsening kidney disease and cardiovascular death in adults with type 2 diabetes and chronic kidney disease FDA Approves Oral Semaglutide as

GLP-1 receptor agonist medications have become one of the fastest-growing pharmaceutical trends in the United States, with millions of patients now using these compounds for weight management and metabolic health

Thats a problem because we do not understand what causes NAION

Most people lose 12 pounds per week on semaglutide, translating to 48 pounds monthly in the first phase of treatment

soared in pre-market trading after Novo Nordisk A/S said it would sell its popular weight-loss drug Wegovy for a reduced price on several telehealth platforms.

Its involved in a number of reactions in the body, such as the contraction and relaxation of muscles and cardiac function

India is expected to be the witness the fiercest competition in 2026, with Semaglutide's patent expiry in March triggering launches by 10-15 players within the following three months.